ADINA Act
On June 22, 2023 the bipartisan Allergen Disclosure In Non-Food Articles (ADINA) Act was introduced in the U.S. House of Representatives and U.S. Senate.
As a groundbreaking legislation, the ADINA Act prioritizes consumer safety and raises awareness about allergens present in prescription and over-the-counter drugs.
This is a major milestone in consumer protection and a testament to our collective efforts in creating a safer and more transparent world – not just for those with chronic illness and mast cell disease, but for all. Let’s raise awareness and spread the word about this transformative legislation!
Resources
Grants given to 26 patients
$115,000 in funds raised
53 volunteers